Chemical characterization, antibacterial activity, in vitro cytotoxicity, and selectivity of the lipid extract from Sargassum filipendula against multidrug-resistant bacteria
Antimicrobial resistance in multidrug-resistant (MDR) bacteria necessitates new therapeutic alternatives, and marine macroalgae represent an underexplored source of bioactive lipids. This study characterized the lipid extract (LE) of Sargassum filipendula and evaluated its antibacterial and cytotoxic profiles against MDR hospital isolates. LE composition was determined by GC-MS, and its thermal behavior by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). Antibacterial activity was evaluated using the broth microdilution method (CLSI M07) against Acinetobacter baumannii , Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , Staphylococcus aureus , and coagulase-negative staphylococci, followed by determination of the minimum bactericidal concentration. Cytotoxicity was assessed in L929 and MDBK cell lines using MTT, Neutral Red, and Lactate Dehydrogenase assays; Hemolytic activity was evaluated using erythrocytes; and selectivity indices (SI) were calculated for each bacterial species. Palmitic acid (61.07%) and oleic acid (15.90%) were the predominant fatty acids. TGA revealed a total mass loss of 82% across two decomposition stages (296 °C, 445 °C), and DSC detected no phase transitions between − 80 and 270 °C. The LE exhibited bacteriostatic activity against all isolates, with MIC values ranging from 1.18 mg/mL ( S. aureus ) to 2.5 mg/mL ( P. aeruginosa ). Cytotoxicity assays yielded IC 50 values ranging from 0.16 to 1.25 mg/mL, and the hemolytic IC 50 was 12.81 mg/mL. However, assay-specific SI values were ≤ 1.06 for adherent cells and 5.12–10.86 for erythrocytes. The S. filipendula LE is a candidate source of antibacterial compounds against MDR bacteria, although purification processes and in vivo validation are required to establish its therapeutic potential.
Authors
- Clarissa P. Frizzo (ORCID: https://orcid.org/0000-0002-1175-7880)
- Sílvia de Oliveira Hübner (ORCID: https://orcid.org/0000-0003-0482-9599)
- Rosélia Maria Spanevello (ORCID: https://orcid.org/0000-0002-5117-2000)
- Patrícia da Silva Nascente (ORCID: https://orcid.org/0000-0002-3137-4107)
- Claudio Martins Pereira de Pereira (ORCID: https://orcid.org/0000-0002-2818-4281)
- Marisa Castro Jara (ORCID: https://orcid.org/0000-0002-9437-3558)
- Fábio Augusto do Nascimento Fialho (ORCID: https://orcid.org/0009-0001-3909-3545)
- MATHEUS PEREIRA DE ALBUQUERQUE (ORCID: https://orcid.org/0009-0007-2175-2374)
- Diego Serrasol do Amaral (ORCID: https://orcid.org/0000-0002-5436-2870)
- Milena De Nardin (ORCID: https://orcid.org/0009-0004-9888-5499)
- Leonardo Wernerb (ORCID: https://orcid.org/0009-0000-2027-6037)
- Wellington Da Rocha da Silva (ORCID: https://orcid.org/0000-0001-7460-1376)
- Vithor Parada Garcia (ORCID: https://orcid.org/0009-0005-1834-6370)
- Rodrigo De Almeida Vaucher (ORCID: https://orcid.org/0000-0003-3496-7335)
Institutions
- Universidade Federal de Pelotas (BR)
- Universidade Federal de Santa Maria (BR)
- Universidade Federal de Santa Catarina (BR)
Publication Details
- Journal
- International Microbiology
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1007/s10123-026-00923-z
- Primary Topic
- Seaweed-derived Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade Federal de Pelotas
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul